Date: 2015-09-23
Type of information: Nomination
Compound:
Company: Argos Therapeutics (USA - NC)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On September 23, 2015, Argos Therapeutics announced the appointment of Robert F. Carey to the company's board of directors. Mr. Carey will replace Mr. Jean Lamarre, who has served on the board since 2013, as a director and as chairman of the company's audit committee. Currently serving as executive vice president and chief business officer for Horizon Pharma plc, Mr. Carey has more than three decades of experience in healthcare investment banking, business development and investor relations. He has served as an advisor on greater than $15 billion in financings, as well as numerous mergers and acquisitions. He was also responsible for starting and managing JMP Securities' healthcare group. Mr. Carey holds a BBA in accounting from the University of Notre Dame.
Financial terms:
Latest news:
